Concomitant initiation of antihypertensive and lipid-lowering therapy, along with reducing pill burden, can significantly improve adherence in patients.
Does concomitant initiation and reduced pill burden improve adherence in patients prescribed antihypertensive and lipid-lowering therapy?
Adherence to concomitant antihypertensive and lipid-lowering therapy is poor but may be improved by concomitant initiation and reducing pill burden.
Absolute Event Rate: 0% vs 0%
Adherence with concomitant AH and LL therapy is poor, with only 1 in 3 patients adherent with both medications at 6 months. Physicians may be able to significantly improve adherence by initiating AH and LL therapy concomitantly and by reducing pill burden.
Richard H. Chapman (Mon,) reported a other. Concomitant initiation of antihypertensive and lipid-lowering therapy, along with reducing pill burden, can significantly improve adherence in patients.